Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
TcNc7BLDyHQXH5NA
